Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2001 | 03-2000 | 03-1999 | 03-1998 | 03-1997 | |
| Sales | 214,484 | 208,612 | 253,240 | 0 | 286,024 |
| Cost of Goods | 201,618 | 182,271 | 238,515 | 0 | 262,133 |
| Gross Profit | 12,866 | 26,341 | 14,725 | 24,414 | 23,891 |
| Operating Expenses | 17,644 | 14,645 | 18,262 | 0 | 0 |
| Operating Income | -4,160 | 11,967 | -3,022 | 0 | 23,891 |
| Interest Expense | 4,923 | 3,460 | 4,418 | 0 | 3,115 |
| Other Income | -2,205 | 0 | -6,636 | 0 | -15,711 |
| Pre-tax Income | -11,288 | 8,507 | -14,076 | 0 | 5,065 |
| Income Tax | -4,510 | 3,264 | -3,997 | 0 | 1,700 |
| Net Income Continuous | -6,778 | 5,243 | -10,079 | 2,333 | 4,026 |
| Net Income | $-6,778 | $5,243 | $-10,079 | $2,333 | $3,365 |
| EPS Basic Total Ops | -1.06 | 0.82 | -1.44 | 0.33 | 0.47 |
| EPS Basic Continuous Ops | -1.06 | 0.82 | -1.44 | 0.33 | 0.56 |
| EPS Diluted Total Ops | -1.06 | 0.81 | -1.44 | 0.33 | 0.47 |
| EPS Diluted Continuous Ops | -1.06 | 0.81 | -1.44 | 0.33 | 0.56 |
| EBITDA(a) | $-337 | $15,396 | $1,437 | $0 | $23,891 |